 |
 |
 |
|
Resistance Analysis of Treatment-Experienced HCV Genotype 1-Infected Patients Re-treated With Sofosbuvir
|
|
|
Reported by Jules Levin;
AASLD 2014 Nov 7-11 Boston
Hongmei Mo,1 Brian P. Doehle,1 Viktoria Gontcharova,1 Krishna Chodavarapu,1 Bittoo Kanwar,1 Ira M. Jacobson,2 Stanislas Pol,3 Diana M. Brainard,1 John G. McHutchison,1 Michael D. Miller1;
1Gilead Sciences, Inc., Foster City, CA; 2Weill Cornell Medical College, New York, NY; 3Université Paris Descartes, Hôpital Cochin, Paris, France







|
|
|
 |
 |
|
|